Financhill
Back

Vertex Pharmaceuticals Vs. Axsome Therapeutics Industry Stock Comparison

Sell
46

VRTX
Vertex Pharmaceuticals

Last Price:
$397.10
Seasonality Move:
6.89%
Sell
33

AXSM
Axsome Therapeutics

Last Price:
$90.86
Seasonality Move:
22.57%
Sell
46
Vertex Pharmaceuticals (VRTX) is a Sell

Is Vertex Pharmaceuticals a Buy, Sell or Hold?

  • The current Vertex Pharmaceuticals [VRTX] share price is $397.27. The Score for VRTX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • VRTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
Axsome Therapeutics (AXSM) is a Sell

Is Axsome Therapeutics a Buy, Sell or Hold?

  • The current Axsome Therapeutics [AXSM] share price is $90.78. The Score for AXSM is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • AXSM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VRTX Stock Price Chart

What is Vertex Pharmaceuticals's stock price today?

  • The Vertex Pharmaceuticals share price today is $397.27
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRTX is experiencing slight buying pressure.

AXSM Stock Price Chart

What is Axsome Therapeutics's stock price today?

  • The Axsome Therapeutics share price today is $90.78
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AXSM is experiencing slight buying pressure.

VRTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -11.99 Sell
Relative Strength Index (14 RSI): 24.09 Sell
Chaikin Money Flow: 2740027 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (437.81 - 475.91) Sell
Bollinger Bands (100): (455.22 - 489.42) Sell

AXSM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.99 Sell
Relative Strength Index (14 RSI): 42.28 Sell
Chaikin Money Flow: 122211 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (92.31 - 99.51) Sell
Bollinger Bands (100): (86.5 - 95.62) Sell

VRTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 446.86 Sell
20-day SMA: 456.96 Sell
50-day SMA: 470.34 Sell
200-day SMA: 457.21 Sell
8-day EMA: 436.6 Sell
20-day EMA: 452.97 Sell
50-day EMA: 463.97 Sell
200-day EMA: 453.34 Sell

AXSM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 92.07 Sell
20-day SMA: 96.19 Sell
50-day SMA: 93.2 Sell
200-day SMA: 83.65 Buy
8-day EMA: 92.29 Sell
20-day EMA: 94.21 Sell
50-day EMA: 93.44 Sell
200-day EMA: 86.24 Buy

Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.74 per share, a decrease next quarter of $0.00 per share, a decrease this year of $14.53 per share, and an increase next year of $18.29 per share.

Axsome Therapeutics Earnings Growth & AXSM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $1.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.08 per share, and an increase next year of $3.78 per share.

Vertex Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Axsome Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):